Duodenal switch: an effective therapy for morbid obesity--intermediate results.

Research paper by A A Baltasar, R R Bou, M M Bengochea, F F Arlandis, C C Escrivá, J J Miró, R R Martínez, N N Pérez

Indexed on: 22 May '01Published on: 22 May '01Published in: Obesity Surgery

---

Join Sparrho today to stay on top of science

Discover, organise and share research that matters to you

Join for free

Join Sparrho today to stay on top of science

Discover, organise and share research that matters to you

Join for free

---

---

Abstract

The duodenal switch (DS) is a variant of the biliopancreatic diversion (BPD), with a vertical subtotal gastrectomy and pylorus preservation.DS was used to treat morbid obesity in 125 patients, with mean BMI 50, with 65% of the patients super obese (SO). Patients have been followed for an intermediate period.The percentage of excess weight loss (%EWL) was > 70% at 1 year, and reached 81.4% at 5 years when 97% of the patients had a %EWL > 50%. Comorbidities were cured or improved in all patients.DS was very effective for the treatment of the morbid obesity in the SO patients.